What is the Takeda Pharmaceutical Co., Ltd. stock price forecast?

Takeda Pharmaceutical Co., Ltd. is currently trading at ¥4,835. View real-time AI analysis on Alpha Lenz.

What is Takeda Pharmaceutical Co., Ltd. insider trading activity?

View the latest insider trading data for Takeda Pharmaceutical Co., Ltd. on Alpha Lenz.

What is Takeda Pharmaceutical Co., Ltd.'s P/E ratio?

Takeda Pharmaceutical Co., Ltd.'s P/E ratio is 70.7.

Takeda Pharmaceutical Co., Ltd.

JPX · 4502

¥4,835

Ask about Takeda Pharmaceutical Co., Ltd.'s future dividend policy...

Alpha Chat Insight

“Takeda Pharmaceutical Co., Ltd. trades at a P/E of 70.7 (premium valuation) with modest ROE of 1.5%.”

Ask for details →

Company Overview

Takeda Pharmaceutical Co., Ltd. is a leading global biopharmaceutical company headquartered in Japan. Its primary purpose is to discover, develop, and deliver innovative medicines that improve patients' lives, focusing on four main therapeutic areas: oncology, rare diseases, neuroscience, and gastroenterology. Takeda also invests in plasma-derived therapies and vaccines. Known for its strong research and development capabilities, Takeda drives advancements through both internal development efforts and strategic partnerships across the globe. As one of the largest pharmaceutical firms by revenue, Takeda plays a significant role in the healthcare industry, impacting patient care worldwide. The company's extensive global network enables it to serve patients in over 80 countries, underscoring its commitment to accessibility and impact in the pharmaceutical market.

CEOMr. Christophe Weber

Websitehttps://www.takeda.com

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Employees47,455

Company Statistics

FY 2025

Profile

¥7,633,850,955,000Market Cap

¥4,581,551,000,000Revenue

0.00Shares Out

47,455Employees

Margins

65.51%Gross

27.05%EBITDA

10.61%Operating

3.82%Pre-Tax

2.36%Net

Valuation

70.73P/E

1.10P/B

1.67EV/Sales

9.49EV/EBITDA

11.27P/FCF

Growth (CAGR)

8.68%Rev 3Yr

6.84%Rev 5Yr

-3.80%Op Inc 3Yr

11.13%Op Inc 5Yr

-22.26%Net Inc 3Yr

19.55%Net Inc 5Yr

Returns

0.74%ROA

1.52%ROE

2.13%ROIC

Financial Health

¥385,113,000,000Cash & Cash Equivalents

¥6,927,252,000,000Net Debt

105.43%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Takeda Pharmaceutical Co., Ltd. trades at a P/E of 70.7 (premium valuation) with modest ROE of 1.5%.”

Ask for details →

Frequently Asked Questions

Takeda Pharmaceutical Co., Ltd. (ticker: 4502) is a company listed on JPX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 47,455 employees. Market cap is $7.6T.

The current price is 4,835 with a P/E ratio of 70.73x and P/B of 1.1x.

ROE is 1.52% and operating margin is 10.61%. Annual revenue is $4.6T.